The Challenges of Surviving Cancer · 14.03.2018 · Cancer Surveillance and Screening...
Transcript of The Challenges of Surviving Cancer · 14.03.2018 · Cancer Surveillance and Screening...
The Challenges of Surviving Cancer
March 14, 2018
M. Alma Rodriguez, M.D.The University of Texas MD Anderson Cancer CenterVice President – Medical Affairs
Conflict of Interest Disclosures
• No conflicts to disclose in relationship to this presentation.
• Discuss cancer survivorship and what the landscape looks like in the US.
• Review data on current and projected survivors nationally.
• Describe the domains of Cancer Survivorship Care
• Review the risks and late effects of Cancer Survivorship
• Review the social and economic challenges Cancer Survivors face
Presentation Objectives
• Describe current and projected US cancer survivorship statistics
• Discuss Survivorship Care Delivery models
• Articulate the domains of survivorship care and the importance of survivorship care as a distinct phase of the cancer continuum
• Utilize the “take-aways” from lessons learned at MD Anderson to envision/improve the quality of life and care for Arkansas cancer survivors
Learning Objectives
An individual is considered a cancer
survivor from the time of diagnosis,
through the balance of his or her life.
Family members, friends, and
caregivers are also impacted by the
survivorship experience, and therefore
included in this definition.
NCI Office of Cancer Survivorship, 1996
Who is a Cancer Survivor?
18 Million Cancer Survivors Projected in 2022
Acute
Intermediate
Long-Term
de Moor J S et al. Cancer Epidemiol Biomarkers Prev2013;22:561-570
Phases of the Journey
Mullan F., N Engl J Med. 1985 313(4):270
ACUTE INTERMEDIATE LONG TERM
Recovery WellnessRemission
Diagnosis
Active Treatment
Immediate Side Effects
Surveillance
For Recurrence
Rehabilitation
Late Effects of
Treatment:
Physical
Psychosocial
• Persistent symptoms after cancer
treatment
• Health effects of new onset years
after treatment
• Difficulty finding physicians after
treatment
• Lack of communication among
physicians
• Emotional symptoms and
disrupted relationships
2005, National Academies Press; IOM , Wash. D.C.
Survivorship Healthcare
Challenge: Lost in Transition
Consequences of cancer survival
• Physical anatomic or functional changes
• Organ toxicity/morbidities that lead to premature onset of
chronic illnesses
• Psychological disturbances
• Socioeconomic burdens
• Increased risk of second malignancies
• In addition, other health co-morbidities can worsen,
particularly in older cancer patients
Distribution of US Cancer
Survivors by Age Groups
Children & Adolescents
Young Adults
Working
Older
As of January 1, 2016
Children & Adolescents (0-19)Young Adults (20-39)
Working Adults (40-59)
21%
4%
74%
1%
Patient related factors: Cancer
survivors are a growing and aging
population*
• One out of every six persons over 65 is a cancer survivor, and 1.4 million were diagnosed more than 20 years ago.
• 70 % of adults diagnosed with cancer today can expect to be alive in five years (CDC).
• Widespread screening, improved treatment and population aging (especially baby-boomers) will lead to continued growth of this cohort.
• Comorbid conditions can be exacerbated by cancer therapies *IOM/NRC From Cancer Patient to Cancer Survivor 2006
Source: Source: DeSantis C, Chunchieh L, Mariotto AB, et al. Cancer Treatment and Survivorship Statistics 2014. Cancer.
Survivor Populations are Unique by
Treatment, Disease, and Health History
• Surgical interventions, radiation ports and doses, as well as chemotherapeutic interventions are unique for
each of the malignant diseases, and
• Differ as well depending on stages or biological or
hormonal characteristics within each disease,
• Hence, the anticipated or potential side effects (short and long term) of treatments will be unique to the
patient’s initial disease presentation, age and other potential comorbid conditions.
• Detection and treatment of late malignancy recurrence or new second malignancies
Cancer Surveillance and Screening
• Lifestyle changes to prevent cancer and risk assessment
Risk Reduction and Cancer Prevention
• Health maintenance and observation of vital organ function
Late Effects / Side Effects Management
• Psychosocial support services to maintain healthy relationships and restored life
Psychosocial Functioning
Domains of Survivorship Care
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 5 10 15 20 25 30
73.4% with at least
one chronic condition
42.4% with a severe
or life-threateningcondition or death
Cum
ula
tive
Inci
dence
Years since Cancer
Cumulative incidence of chronic physical health conditions among 10,397 young adult survivors of childhood cancer
Childhood Cancer Survivor Study
Oeffinger KC, et al. N Engl J Med, 2006
Cause-Specific Mortality in Early Stage Breast
Cancer Survivors
Breast cancer
Cardiovascular disease
Second malignancy
Hooning MJ, et al. Int J Radiation Oncology Biol Phys, 2006
Beard CJ, et al. Cancer, 2013
Cumulative incidence by causes of death for patients with stage I testicular seminoma
Second cancer
Cardiovascular
disease
Testicular cancer
SEER Registry; N=9193 men, diagnosed 1973-2001
Risk factors for second
malignancies
• Treatment related• Radiation, chemotherapy
• Hereditary• Genetic syndromes
• Environmental• Exposure to harmful conditions
• Type of primary cancer• Some cancers have risk of other second primary cancers for
unknown reasons
• Health related• Infectious agents
• Autoimmune disorders
• Lifestyle factors
Health and Lifestyle
• Smoking: lung, oral cavity
• Obesity: colon, breast, ovarian
Tiers of Medical Risk in Long-term
Survivors
Prevention
Oncology
InternalMedicine
Psychosocial Support/Symptom Management
Tier 3: High risk of relapse; active indolent/controlled disease; intensive chemotherapy/radiation/SCT with high risk of sequelae= SCT, Chronic, & High-Risk Cancers
Tier 2: Patients with complications/risk of treatment or second malignancies = Chemo, Radiation
Tier 1: Very low risk of complications or relapse = Surgery
Algorithm: Domains of Care
Algorithm: Domains of Care
Survivorship Care Delivery Models
in the US
Model Examples
Oncology-based• Disease-based programs
• Treatment-based
programs
• Comprehensive stand-
alone programs
• Breast, colorectal, genitourinary cancers
• Hematopoietic stem cell transplant
• All disease type cancer survivors
Shared Care• Shared care between
oncology practice &
primary care provider
• Survivor is seen at cancer center and co-
followed by the community primary care
provider
Community-based• Oncologist, PCP, allied
health professional
• Includes referrals to community providers
such as physical therapist, nutrition
counselors, etc.
Psychological Health
• Anxiety or fear over
relapse
• Depression
• Grief over loss of
health, lifestyle or work
• Body image
• Disrupted relationships
Returning to Life Activities
• Fatigue is a common
complaint – can be
improved by exercise
• Impaired immunity is a
consideration for
travelers
• Gradual integration to
normal prior level of
activity recommended
• Activity is important for
health and weight
management
Sexual Health
• Decreased Libido: consider hormone
levels, thyroid function
• Menopause symptoms
that are uncomfortable
• Psychological factors:
– Anxiety/fear
– Depression
– Body image
Fertility
• Strategies to
preserve fertility prior
to treatment
• Post treatment
evaluation for fertility:
– Sperm counts at
least 6 months
after treatment
– Return of menses
may not always
relate to fertility
Return to Work
• Factors associated with successful return to work are
1. younger age; 2. higher
education level ; 3. employment prior to illness
• (Mosher et al, Psychooncology 2009)
• 84% of those who did not experience relapse of their
primary malignancy were employed at 5 years post SCT.
• (Syrjala et al, JAMA 2004)
Annual Lost Productivity, Adults age 18-64, MEPS, 2008-2010
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Interference with job tasks
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Key findings: Employment & Hours Worked
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Key Findings
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Key findings: Predictors of poor work outcomes
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Economics and Insurance• A study in 10 year HSCT survivors
indicated 24% had experienced denial
of health insurance, and 27 % were
denied life insurance, compared to age
matched cohorts which reported no denials
• Those with health insurance had higher premiums, or lesser coverage which
made health care for late effects difficult
or unaffordable Syrjala KL, et al; JCO 2005.
• A report by the CDC also noted that
cancer survivors had much higher out
of pocket expenses, compared to age
and gender matched cohorts– CDC, Morbidity and Mortality Report, 6/2014
Slide 6
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Summary
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Strategies for addressing financial hardship
Presented By K Yabroff at 2018 Cancer Survivorship Symposium: Advancing Care and Research
The Challenge of Surviving Cancer
• The challenge in overcoming cancer is not only to find therapies that will prevent or arrest the disease quickly, but also to map the middle ground of survivorship and minimize its medical and social hazards
– Fitzhugh Mullan. Seasons of Survival: Reflections by a Physician with Cancer. NEJM 1985
• Alfano, C. M., Smith, T., de Moor, J. S., Glasgow, R. E., Khoury, M. J., Hawkins, N. A., … Rowland, J. H. (2014). An Action Plan for Translating Cancer Survivorship Research Into Care. JNCI Journal of the National Cancer Institute, 106(11), dju287. http://doi.org/10.1093/jnci/dju287
• Blanch-Hartigan, D., Forsythe, L. P., Alfano, C. M., Smith, T., Nekhlyudov, L., Ganz, P. A., & Rowland, J. H. (2014). Provision and Discussion of Survivorship Care Plans Among Cancer Survivors: Results of a Nationally Representative Survey of Oncologists and Primary Care Physicians. Journal of Clinical Oncology, 32(15), 1578–1585. http://doi.org/10.1200/JCO.2013.51.7540
• Cancer Treatment & Survivorship Fact & Figures 2016-2017https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2016-2017.pdf
• Caruso, R., Pasquale, C. D., Lichosik, D., Dellafirore, F., & Pittella, F. (2013). Report on the 2013 European Multidisciplinary Cancer Congress—ECC 17, Amsterdam, 27 September–1 October 2013: nursing highlights. Ecancermedicalscience, 7, 367. http://doi.org/10.3332/ecancer.2013.367
• Catt, S., Starkings, R., Shilling, V., & Fallowfield, L. (2017). Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review. Journal of Cancer Survivorship, 11(2), 211–232. http://doi.org/10.1007/s11764-016-0580-1
• de Moor JS, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol. Biomarkers Prev. 2013;22:561–570. doi: 10.1158/1055-9965.EPI-12-1356
• de Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., … Rowland, J. H. (2013). Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 22(4), 561–570. http://doi.org/10.1158/1055-9965.EPI-12-1356
• Halpern, M. T., Viswanathan, M., Evans, T. S., Birken, S. A., Basch, E., & Mayer, D. K. (2015). Models of Cancer Survivorship Care: Overview and Summary of Current Events. Journal of Oncology Practice, e19-e27.
• Kahana, E., Kahana, B., Langendoerfer, K. B., Kahana, B., & Smith-Tran, A. (2016). Elderly Cancer Survivors Reflect on Coping Strategies During the Cancer Journey. Journal of Gerontology & Geriatric Research, 5(5), 337. http://doi.org/10.4172/2167-7182.1000337
• Liu, Q., Leisenring, W. M., Ness, K. K., Robison, L. L., Armstrong, G. T., Yasui, Y., & Bhatia, S. (2016). Racial/Ethnic Differences in Adverse Outcomes Among Childhood Cancer Survivors: The Childhood Cancer Survivor Study. Journal of Clinical Oncology, 34(14), 1634–1643. http://doi.org/10.1200/JCO.2015.66.3567
Suggested Reading
Suggested Reading
• Nekhlyudov, L., O’Malley, D. M., & Hudson, S. V. (2017). Integrating Primary Care Providers in the Care of Cancer Survivors: Gaps in Evidence and Future Opportunities. The Lancet. Oncology, 18(1), e30–e38. http://doi.org/10.1016/S1470-2045(16)30570-8
• Nekhlyudov, L., Ganz, P. A., Arora, N. K., & Rowland, J. H. (2017). Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship. Journal of Clinical Oncology, 35(18), 1978–1981. http://doi.org/10.1200/JCO.2016.72.1373
• O’Malley, D., Hudson, S. V., Nekhlyudov, L., Howard, J., Rubinstein, E., Lee, H. S., … Crabtree, B. F. (2017). Learning the Landscape: Implementation Challenges of Primary Care Innovators around Cancer Survivorship Care. Journal of Cancer Survivorship : Research and Practice, 11(1), 13–23. http://doi.org/10.1007/s11764-016-0555-2
• Rowland, J. H., Kent, E. E., Forsythe, L. P., Loge, J. H., Hjorth, L., Glaser, A., … Fosså, S. D. (2013). Cancer Survivorship Research in Europe and the United States: Where have we been, where are we going, and what can we learn from each other? Cancer, 119(0 11), 2094–2108. http://doi.org/10.1002/cncr.28060
• Stone, D. S., Ganz, P. A., Pavlish, C., & Robbins, W. A. (2017). Young adult cancer survivors and work: a systematic review. Journal of Cancer Survivorship, 11(6), 765–781. http://doi.org/10.1007/s11764-017-0614-3
References
Presented By Cathy Bradley at 2018 Cancer Survivorship Symposium: Advancing Care and Research
Thank you!
Questions!